Post-marketing clinical surveillance plan (PMCF) to evaluate the safety and clinical effectiveness of the Supraflex Cruz TM coronary stent in the treatment of multivessel coronary artery disease
CLINICAL RESEARCH WITH PROD. SANIT.
Clinical trial information
- Promoter: EPIC FOUNDATION
- Execution start: 05/05/2023
- End of execution: 30/07/2025
- IP: JUAN CABALLERO BORREGO